scholarly article | Q13442814 |
P50 | author | American Society of Clinical Oncology | Q2843019 |
College of American Pathologists | Q5146628 | ||
P2093 | author name string | David L Rimm | |
David Huntsman | |||
Annette Molinaro | |||
Malini Harigopal | |||
Robert L Camp | |||
Christopher B Moeder | |||
Andrew Robinson | |||
Karen Gelmon | |||
Jennifer M Giltnane | |||
P433 | issue | 34 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | Erb-b2 receptor tyrosine kinase 2 | Q415271 |
P304 | page(s) | 5418-5425 | |
P577 | publication date | 2007-12-01 | |
P1433 | published in | Journal of Clinical Oncology | Q400292 |
P1476 | title | Quantitative justification of the change from 10% to 30% for human epidermal growth factor receptor 2 scoring in the American Society of Clinical Oncology/College of American Pathologists guidelines: tumor heterogeneity in breast cancer and its impl | |
P478 | volume | 25 |